Stem Cell Transplantation is used primarily to treat life-threatening blood disorders, such as leukemia and Hodgkin's disease. Oncology/Hematology Care's Stem Cell Transplant program is led by Dr. Randolph Broun, program director, and Dr. James Essell and Dr. Duane Sigmund. These physicians lead the only adult stem cell transplant program in the Tri-State region. The physicians have undergone extensive training in medical oncology, hematology and stem cell transplant and work with a multidisciplinary team of support providers based at the Jewish Hospital in Kenwood.

Stem Cell Transplantation can be either autologous or allogeneic. With autologous tranplant, the physician extracts healthy marrow from the patient, administers high-dose chemotherapy, and then reinfuses the patient's own marrow or stem cells back. With allogeneic transplant, healthy donated bone marrow is used to replace a patient's diseased bone marrow. Donors can be either related to the patient or unrelated. Unrelated donors are located through the National Marrow Donor Program.

Bone Marrow or Stem Cell Transplantation can lead to a cure of a disease that is otherwise fatal. Oncology/Hematology Care remains on the cutting edge of research and improved technology to make this treatment a viable alternative for a growing number of patients.